Clear science for curious people
ScienceBlog.com
Writer at Science Blog

ScienceBlog.com

Contributor

Profile →

Health

Using carbon nanotubes in lithium batteries can dramatically improve energy capacity

CAMBRIDGE, Mass. -- Batteries might gain a boost in power capacity as a result of a new finding from researchers at MIT. They found that using carbon nanotubes for one of the battery's electrodes produced a significant increase -- up to tenfold -- in the amount of power it could deliver from a given weight of material, compared to a conventional lithium-ion battery. Such electrodes might find applications in small portable devices, and with further research might also lead to improved batteries for larger, more power-hungry applications. To produce the powerful new electrode material, the team used a layer-by-layer fabrication method, in which a base material is alternately dipped in solutions containing carbon nanotubes that have been treated with simple organic compounds that give them either a positive or negative net charge. When these layers are alternated on a surface, they bond tightly together because of the complementary charges, making a stable and durable film. The findings, by a team led by Associate Professor of Mechanical Engineering and Materials Science and Engineering Yang Shao-Horn, in collaboration with Bayer Chair Professor of Chemical Engineering Paula Hammond, are reported in a paper published June 20 in the journal Nature Nanotechnology. The lead authors are chemical engineering student Seung Woo Lee PhD '10 and postdoctoral researcher Naoaki Yabuuchi. Batteries, such as the lithium-ion batteries widely used in portable electronics, are made up of three basic components: two electrodes (called the anode, or negative electrode, and the cathode, or positive electrode) separated by an electrolyte, an electrically conductive material through which charged particles, or ions, can move easily. When these batteries are in use, positively charged lithium ions travel across the electrolyte to the cathode, producing an electric current; when they are recharged, an external current causes these ions to move the opposite way, so they become embedded in the spaces in the porous material of the anode. In the new battery electrode, carbon nanotubes -- a form of pure carbon in which sheets of carbon atoms are rolled up into tiny tubes -- "self-assemble" into a tightly bound structure that is porous at the nanometer scale (billionths of a meter). In addition, the carbon nanotubes have many oxygen groups on their surfaces, which can store a large number of lithium ions; this enables carbon nanotubes for the first time to serve as the positive electrode in lithium batteries, instead of just the negative electrode. This "electrostatic self-assembly" process is important, Hammond explains, because ordinarily carbon nanotubes on a surface tend to clump together in bundles, leaving fewer exposed surfaces to undergo reactions. By incorporating organic molecules on the nanotubes, they assemble in a way that "has a high degree of porosity while having a great number of nanotubes present," she says. Lithium batteries with the new material demonstrate some of the advantages of both capacitors, which can produce very high power outputs in short bursts, and lithium batteries, which can provide lower power steadily for long periods, Lee says. The energy output for a given weight of this new electrode material was shown to be five times greater than for conventional capacitors, and the total power delivery rate was 10 times that of lithium-ion batteries, the team says. This performance can be attributed to good conduction of ions and electrons in the electrode, and efficient lithium storage on the surface of the nanotubes. In addition to their high power output, the carbon nanotube electrodes showed very good stability over time. After 1,000 cycles of charging and discharging a test battery, there was no detectable change in the material's performance. The electrodes the team produced had thicknesses up to a few microns, and the improvements in energy delivery only were seen at high-power output levels. In future work, the team aims to produce thicker electrodes and extend the improved performance to low-power outputs as well, they say. In its present form, the material might have applications for small, portable electronic devices, says Shao-Horn, but if the reported high power capability were demonstrated in a much thicker form -- with thicknesses of hundreds of microns rather than just a few -- it might eventually be suitable for other applications such as hybrid cars. While the electrode material was produced by alternately dipping a substrate into two different solutions -- a relatively time-consuming process -- Hammond suggests that the process could be modified by instead spraying the alternate layers onto a moving ribbon of material, a technique now being developed in her lab. This could eventually open the possibility of a continuous manufacturing process that could be scaled up to high volumes for commercial production, and could also be used to produce thicker electrodes with a greater power capacity. "There isn't a real limit" on the potential thickness, Hammond says. "The only limit is the time it takes to make the layers," and the spraying technique can be up to 100 times faster than dipping, she says. Lee says that while carbon nanotubes have been produced in limited quantities so far, a number of companies are currently gearing up for mass production of the material, which could help to make it a viable material for large-scale battery manufacturing. Source: "High-power lithium batteries from functionalized carbon nanotube electrodes." Seung Woo Lee, Naoaki Yabuuchi, Betar M. Gallant, Shuo Chen, Byeong-Su Kim, Paula T. Hammond, & Yang Shao-Horn. Nature Nanotechnology. 19 June 2010.

Jun 20, 2010

Health

Penn bioengineers create simulator to test blood platelets in virtual heart attacks

PHILADELPHIA -- - A team of bioengineers from the University of Pennsylvania Institute for Medicine and Engineering have trained a computer neural network model to accurately predict how blood platelets would respond to complex conditions found during a heart attack or stroke. Using an automated, robotic system, they exposed human blood platelets to hundreds of different combinations of biological stimuli like those experienced during a heart attack. This was done by fingerprinting each platelet sample with 34,000 data points obtained in response to all possible pairs of stimuli. The team applied the system to predict intracellular calcium signaling responses of human platelets to any combination of up to six different agonists used at different dosages and even applied at different times. The model predicted platelet responses accurately, even distinguishing between 10 blood donors, demonstrating an efficient approach for predicting complex chemical responses in a patient-specific disease milieu. The strategy involves selecting molecules that react with blood platelets under high-risk situations, such as a heart attack, measuring the cellular responses to all pairwise combinations of stimuli in a high-throughput manner and then training a two-layer, nonlinear, neural network with the measured cellular responses. For platelets, it was discovered that the complexity of integrating numerous signals can be built up from the responses to simpler conditions involving only two stimuli. "With patient-specific computer models, it is now possible to predict how an individual's platelets would respond to thousands of 'in silico' heart-attack scenarios," said Scott L. Diamond, professor of chemical and biomolecular engineering and the director of the Penn Center for Molecular Discovery. "With this information we can identify patients at risk of thrombosis or improve upon current forms of anti-platelet therapies." The research team developed its experimental/computational technique, called Pairwise Agonist Scanning, or PAS, to define platelet response to combinations of agonists, chemicals that bind in this case to platelet cells, initiating a cellular response. Future research would include the application of PAS to clinical stimuli that platelets encounter such as epinephrine, serotonin and nitric oxide, which would map a major portion of the entire platelet response. The use of PAS with certain pharmacological agents would allow further assessment of individual clinical risk, or sensi¬tivity to therapy. Platelet cells respond in a patient-specific manner to multiple signals, and their reaction to thrombotic signals is central to the 1.74 million heart attacks and strokes, 1.115 million angiograms and 0.652 million stent placements in the United States each year. For Diamond, platelets are also ideal cellular systems for quantifying the effects of multiple signaling pathways because they are anucleate, easily obtained from donors and amenable to automated liquid handling. Few experi¬mental or computational tools are available for building a global understanding of how the platelet integrates multiple stimuli present at varying levels. Researchers working in systems biology seek to understand blood as a reactive biological fluid whose function changes through a variety of physical and chemical stimuli such as hemodynamics, vessel-wall characteristics, platelet metabolism, numerous coagulation factors in plasma and small molecules released during thrombosis. Because platelet cells respond to numerous signals and chemical doses and integrate their responses to these stimuli, effi¬cient and speedy computational methods are needed to survey such high-dimensional systems. Evaluating the cellular response to merely pairs of stimuli offers a direct and rapid sampling of the cellular response, which can be built up to predict even more complex situations and may eventually lead to a predictive clinical tool for cardiovascular disease. The study, published in the current issue of Nature Biotechnology and supported by the National Institutes of Health, was conducted by Diamond and Manash S. Chatterjee of the Department of Chemical and Biomolecular Engineering, Jeremy E. Purvis of the Department of Genomics and Computational Biology and Lawrence F. Brass of the Department of Medicine at Penn. All are members of the Institute for Medicine and Engineering at Penn.

Jun 20, 2010

Health

Targeting disease remission has socio-economic benefits over low disease activity

Rome, Italy, Saturday 19 June 2010: Achieving disease remission in patients with rheumatoid arthritis (RA) provides superior outcomes across measures of socio-economic importance including work productivity and quality of life according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. These Austrian findings are reported in addition to improvements in measures of physical functioning, when compared with RA patients achieving low disease activity (LDA). Results from this cross-sectional study of 356 patients showed statistically significant differences (p= < 0.01) between RA patients who had achieved disease remission (REM, defined by the Clinical disease activity Index (CDAI), a composite index including objective and patient derived scores) compared to those who had achieved LDA across several domains including: Effect on work productivity, based on results of the Work Productivity and Activity Impairment (WPAI*) index: impairment while working 11.3% vs. 27.2%, overall activity impairment 18.1% vs. 33.8%, REM vs LDA respectively Impact on quality of life, based on results of the Euro Qol (5D EQ-5D)* index: 0.89 vs. 0.78 and the SF-36 PCS* index: 46.2 vs. 37.8 Impact on physical functioning, based on results of the Health Assessment Questionnaire (HAQ*) scores: 0.38 vs. 0.75. "We know that RA as a chronic disease often has a long term impact on patients' functional ability, affecting not only patients' well-being but also their working lives. The majority of those affected report a loss of productivity at work, and many even have to stop work altogether," said Dr. Helga Radner, Department of Rheumatology, Medical University Vienna, Austria and lead author of the study. "Our study results show that the benefits of achieving clinical remission are worthwhile, especially from a socio-economic point of view, as it decreases the 'burden of disease' not only for patients but also for society on a wider scale. The findings reveal that remission is even superior to an almost perfect disease activity state, namely low disease activity, therefore our major task in treating RA-patients should be its achievement and maintenance" Interestingly, researchers found that the emotional aspects of the disease activity measures were similarly reported in patients in remission and in low disease activity indicating that once disease activity or symptom levels are reduced to a certain level, emotional discord may stabilise. Longitudinal analysis over one year showed significant improvements when comparing the two patient populations in the following areas: Quality of life (EQ-5D); 0.89 vs. 0.80 (REM vs. LDA respectively), p < 0.001 Percent of overall activity impairment (WPAI) per year; 12.2% vs. 31.0%, p < 0.001 Physical disability (HAQ); 0.23 vs. 0.69, p= < 0.001 Significant differences between REM and LDA were not seen in the domain of percentage impairment while working (8.3% vs. 20.0% (REM vs. LDA respectively), p=0.096). This study of 356 patients registered at the Department of Rheumatology at the Medical University of Vienna involved one cross sectional analysis (at a single time point) of RA patients, with 34 patients achieving REM (CDAI ≤2.8) and 66 patients achieving LDA (2.8≤CDAI<1). * HAQ is a disability index used by physicians to measure an individual's physical functioning and assesses ability to undertake everyday activities such as dressing, eating and walking, and whether assistance from another person or disability aids is required. A higher score indicates greater disability. The WPAI questionnaire measures work time missed and work and activity impairment due to a specified health problem during the last 7 days. The (EQ-5D) is a health-related quality of life scale consisting of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) to which responses can be made at three levels of severity (no problems/some or moderate problems/extreme problems). The Short Form 36 (SF36) SF-36 is a multi-purpose health survey which yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures. The Clinical Disease Activity Index allows the assessment of actual disease activity, response to therapy, and achievement of particular states such as remission. The simplicity of the scoring system facilitates patient understanding of the level of their disease activity. Abstract Number: SAT0026 For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress Press Office on the 1st floor in Hall 5 of the Congress Centre during EULAR 2010 or on: Email: [email protected] Rory Berrie: Onsite tel: +44 7901 513 297 Caroline Butt: Onsite tel: +44 7789 270 392 About EULAR The European League Against Rheumatism (EULAR) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. In line with The European Union of Medical Specialists (UEMS), EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems. The aims of EULAR are to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with rheumatic diseases. EULAR 2010 is set to be the biggest rheumatology event in Europe with over 15,000 scientists, physicians, allied health professionals, and related audiences in attendance from over 100 countries. Over the course of the congress, almost 300 oral and more than 1600 poster abstract presentations will be featured, with 300 invited speaker lectures taking place in more than 140 sessions. To find out more about the activities of EULAR, visit: www.eular.org

Jun 19, 2010

Brain & Behavior

UM scientists design intelligent 3-D simulation robots to compete in the Robocup 2010

CORAL GABLES, Fl (June 18, 2010) -- A University of Miami (UM) researcher will be presenting his work on Robotics and Artificial Intelligence (AI) at the 14th annual RoboCup World Championship and Symposium, an international robotic event whose goal is to advance AI and intelligent robotics research. Ubbo Visser, research associate professor of computer science at UM College of Arts and Sciences and team leader for the UM robotics team RoboCanes, will describe the architecture of the multiagent system (MAS) and discuss motion capture techniques for graphical animation. Visser will share his findings in a paper titled: "TopLeague & Bundesliga Manager: New generation online soccer games" and participate in the 3D simulation soccer league with the RoboCanes, designed by the AI & Games group at UM. The event will take place in Singapore, June 19-25. "The idea of using soccer as a test bed for robots is to learn about the needs of agents, or robots that act in real-time, dynamic, and adversarial environments," says Visser. "To understand what it takes for a robot to integrate knowledge and put information into context so that it can make decisions in a split second: that is one of the hardest problems in AI and robotics to solve right now." RoboCup (originally called The Robot World Cup Soccer Games and Conferences) started in 1997, and over the years has become the prevalent robotics competition in the world. The primary focus of the event is soccer games; it involves more than 3,000 researchers, about 450 teams and participants from over 40 countries. For the event, the contestants develop autonomous robots and software agents and take part in games, simulations, conferences, and educational programs, but RoboCup is not just about playing games, explains Visser, who is one of the Trustees of the RoboCup Federation. "There is a noble goal behind this work, namely to understand what's going on if we send robots in the field and let them do the work of humans," says Visser. "Doing this work gives one a lot of respect for the human mind; people can have this huge amount of experience of what to do in unforeseen situations and that is exactly what we are trying to solve with robots: what techniques are successful in these sorts of situations is what we are touching on." The University of Miami team the RoboCanes is one of only two US teams participating in the 3D simulation soccer league. Like the real World Cup in soccer, in RoboCup a team has to qualify to participate. One way to qualify is to win a regional open; another is fulfilling guidelines and qualification rules. The games are divided into the following leagues: Simulation League -- 2D and 3D; Small Size Robot League, Middle Size Robot League, Four-Legged Robot League, and the Humanoid League. This is the first time UM participates in this event. To take part in this competition, the AI & Games Group had to develop a soccer team of six 3D robots, meaning they have a complete resemblance to a physical robot. The robots are autonomous and have the ability to acquire strategic knowledge and real-time reasoning and can communicate and cooperate with each other during a game. Knowing how difficult it is to win this event, the team is setting their sights to making it through its first round. "The idea is to develop our team and to be successful; this means to pass the first round this year," Visser says. "If we manage that, it will be a great success, but we would like to evolve into the real robot league, next year." The other US team participating in the 3D simulation soccer league is from the University of Texas at Austin. In addition to the RoboCupSoccer, the event has three other areas: RoboCupRescue, RoboCup@Home and RoboCupJunior. To observe a video clip of RoboCanes in action, go to: http://www.cs.miami.edu/aigames About the University of Miami The University of Miami's mission is to educate and nurture students, to create knowledge, and to provide service to our community and beyond. Committed to excellence and proud of the diversity of our University family, we strive to develop future leaders of our nation and the world. www.miami.edu

Jun 18, 2010

Health

Saint Louis University investigators perfect new version of blood-regulator thrombin

ST. LOUIS -- In research led by a Saint Louis University investigator, molecular biologists have discovered a way to harness the enzyme thrombin's anti-blood clotting properties. The finding opens the door to new medications that will treat diseases related to thrombosis, the presence of blood clots in blood vessels, which is responsible for nearly a third of all deaths in the U.S. "Thrombosis is one of the most prevalent causes of fatal disease," said lead researcher Enrico Di Cera, M.D., chair of the department of biochemistry and molecular biology at Saint Louis University School of Medicine. "If we could develop an anti-thrombotic drug that didn't carry a risk of hemorrhage, it would revolutionize the treatment of cardiovascular disease, the leading cause of death in the U.S. and Western world. "This research carries us closer to that goal." Blood clotting has long ensured our survival, stopping blood loss after an injury. On the other hand, if triggered in the wrong conditions, clotting can lead to debilitating or fatal conditions like heart attack, stroke and deep vein thrombosis. Funded by the National Institutes of Health, and published in the June 18, 2010 edition of The Journal of Biological Chemistry (Vol. 285. No. 25), researchers zeroed in on thrombin, a vitamin K-dependent enzyme key to blood coagulation. An unusual enzyme, thrombin performs distinct and even opposing functions, acting as a pro-coagulant, pro-thrombotic but also as an anti-coagulant factor depending on which target protein -- fibrinogen, PAR1 or protein C -- becomes activated in the blood. Researchers studied thrombin to decipher the structure-function code that enables this protein to do so many different things. Tackling this problem far below the level of tissue and organs, molecular biologists looked deep inside the structure, examining thrombin's amino acids to note how they behave and interact with each other. Using protein engineering, researchers produced mutations in the enzyme's amino acid sequence, carefully taking out pieces and replacing them, a few at a time, to find the exact locations that influence the function of thrombin. Once they found these "hot spots," researchers went even further -- trying each of the 20 natural amino acids to see which mutation would allow them to turn on and off the pro-coagulant, pro-thrombotic and anti-coagulant functions. "We asked the question, what if we can take this enzyme and dissociate the functions, allowing only the function we want?" said Di Cera. In earlier research, Di Cera's team did just that. They engineered thrombin to promote activity toward protein C -- the anticoagulant target protein -- and minimize activity toward fibrinogen and PAR1 -- the procoagulant and prothrombotic targets. "In 2000, we engineered a thrombin mutant with potent anticoagulant properties both in vitro and in vivo and we are moving this mutant to a phase I trial," said Di Cera. "In this study, however, we pressed further. We wanted to optimize this mutant to completely abrogate activity toward fibrinogen and PAR1." "With this research we optimized the mutant so that there is no clotting at all. Furthermore, we generated a new mutant with exclusive prothrombotic activity, thereby demonstrating that the individual functions of thrombin can be dissociated by replacing a single amino acid in the protein." Once clinical trials are performed, researchers hope to have developed an alternative to heparin, a blood thinner that is used to prevent blood clots and is often used before surgery, but which also causes allergic reactions, dosage challenges and bleeding. "Heparin is a brute-force remedy that shuts down all thrombin functions, including its beneficial anti-coagulant role," said Di Cera. "Our approach is a new strategy that like a smart bomb only targets the functions we want to turn off." Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious disease.

Jun 18, 2010

Brain & Behavior

Aerogeophysical survey provides promising prospects of economic development in Afghanistan

(WASHINGTON, D.C. • June 17, 2010) -- Analyzing nearly 20 terabytes of data collected from 220 mission flight-hours covering more than half of Afghanistan, Naval Research Laboratory and the U.S. Geological Survey investigators reveal several potential major oil and gas sedimentary basins, mineral-rich regions, and hydrologic resources for agriculture and economic development as recently reported by Department of Defense. Flights administered by Naval Research Laboratory Scientific Development Squadron One (VXS-1) were flown using NP-3D Orion turboprop aircraft specially equipped with a suite of unique state of the art remote sensing technology that included dual gravimeters, scalar and vector magnetometers, a digital photogrammetric camera, hyperspectral imager and an L-band polarimetric synthetic aperture radar. Photogrammetric mosaics and other imagery processed by USGS have also been provided to the National Geospatial-Intelligence Agency (NGA) for incorporation into Department of Defense image libraries and are being used for economic analysis projects by the United States Agency for International Development (USAID) for construction and development projects and to the government of Afghanistan for a myriad of uses to include geologic exploration, hydrologic resource management and earthquake hazard analysis. "This imagery will be enormously important for seismic and flood hazard analysis, development of roads, pipelines and property boundaries, and other civil infrastructure projects and agriculture resource management," states NRL Chief Scientist, Dr. John Brozena. "The data we have amassed and are analyzing today could prove invaluable to the future economic redevelopment of Afghanistan," added Brozena. The country faces dual challenges of suppressing Taliban and al-Qaeda operations and developing the basis of a legal and sustainable economy that minimizes popular support for terrorist activity. The combined efforts of NRL, USGS, and the crew of VXS-1 to conduct a major airborne remote sensing and mapping project contribute greatly to both these objectives. The aerogeophysical project Rampant Lion (2006), sponsored by the government of Afghanistan, Office of Naval Research (ONR) and NGA, marked a technological milestone in the integration and successful operation of the largest set of diverse airborne geophysical sensors ever flown and the first deployment of NRL scientists into a combat theater since World War II.

Jun 18, 2010

Technology

The key role of the oceans' subpolar regions in the climate control of the tropics is confirmed

An international team of researchers, led by the members of the Institut de Ciència i Tecnologia Ambientals (ICTA) at the Universitat Autònoma de Barcelona (UAB), has published the first registers of the evolution of Northern Pacific and Southern Atlantic sea-surface temperatures, dating from the Pliocene Era -some 3.65 million years ago- to the present. The data obtained in the reconstruction indicate that the regions closer to the poles of both oceans have played a fundamental role in climate evolution in the tropics. This research solves another piece of the jigsaw puzzle that is the study of oceanic behaviour and its influence on climate. The results are based on the doctoral thesis presented by Dr Alfredo Martínez-García (currently, a researcher with both the Swiss Federal Institute of Technology, ETH Zurich, and with the DFG-Leibniz Centre at the University of Postdam, Germany). The thesis was undertaken at the UAB and directed by Dr Antoni Rosell Melé, an ICTA ICREA researcher and adjunct professor with the Department of Geography. This work was carried out in collaboration with Dr Gerald H. Haug, of ETH and DFG-Leibniz Centre; Dr Erin L. McClymont of Newcastle University (UK); and Dr Rainer Gersonde, of the Alfred Wegener Institute (Germany). The study of Pliocene climate has now been the object of intense research for several years, as this era represents -- in the Earth's history -- the most recent climatic period in which, over a sustained period of time, average temperatures on the planet were significantly higher than those of the present. As a result, the Pliocene is thought of as a climatic period that might be representative of the Earth's climate in future conditions of global warming. In this study, the researchers analysed marine sediment collected by the Integrated Ocean Drilling Program (an international initiative), and measured its composition of organic compounds termed alkenones. Reconstruction of the surface temperature in the Northern Pacific and Southern Atlantic has enabled a simultaneous sea-surface cooling to be identified in the subpolar regions of the two hemispheres in the period between 1.8 and 1.2 million years ago. This finding coincides in time with the formation of the equatorial Pacific cold tongue -- which currently almost disappears during the "El Niño" phenomenon. Previous studies have shown that, during the warm conditions of the Pliocene, this cold tongue was not present; thus, conditions in the equatorial Pacific were similar to those of a permanent "El Niño" episode. Data obtained in this study indicate that the cooling and expansion of polar waters towards the tropics intensified atmospheric circulation. And this fact played a fundamental role in the equatorial Pacific, leading to the reduction in depth of the thermocline -- the layer of ocean water in which the temperature fall rapidly -- and therefore to the appearance of the equatorial cold tongue that we can currently observe. The research undertaken provides empirical evidence, previously suggested by studies using climatic models, that the oceans in high latitudes may play a key role in the control of tropical climate and, most especially, in the thermocline depth in the equatorial Pacific. The study contributes to the debate on which regions on the planet are those that, when their local climates change, give rise to processes of global change. It is often indicated that these regions are found in the tropics, since, when phenomena such as "El Niño" occur, they have global repercussions. This study provides evidence for the key role that may be played by the polar regions of the planet. Currently, high latitudes are the ones that appear to be responding in the clearest way to global warming. Given the direct relationship established in this study between high-latitude climate variation and thermocline depth in the equatorial Pacific, it appears possible that the equatorial Pacific cold tongue will eventually respond to the current warming, giving rise to a climatic scenario similar to that of the Pliocene.

Jun 18, 2010

Health

Chinese systemic lupus erythematosus data reveal differences in epidemiology across continents

Rome, Italy, Friday 18 June 2010: The Chinese Systemic Lupus Erythematosus (SLE) Treatment and Research Group (CSTAR) announced interim epidemiological information on SLE patients in China today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Robust data on SLE patients has been scarce to date; but now CSTAR provides the first online registry of this magnitude in China. To date the registry has collated data from 2,104 SLE patients across 30 Chinese provinces. An initial comparative analysis of CSTAR data with other similarly sized cohort analyses undertaken across the USA, Europe and Malaysia revealed the following key differences in the main characteristics and disease manifestations between Chinese SLE patients and those studied in the comparative cohorts: •Over half (57.4%) of Chinese SLE patients present with concurrent haematological disorders compared with 48% of Malaysian patients and only 18.2% of European patients •Almost half (45.8%) of Chinese patients are also diagnosed with kidney disease compared with 27.9% of European patients and only 7.4% of Malaysian patients •Conversely, neurological manifestations are only seen in 4.5% of Chinese SLE patients compared with 19.4% of European patients and 12.1% of US patients. "Other SLE registries exist across the world, but this is a first for a nation with the largest global population. The research group set out to clarify the epidemiology of SLE in China and provide valuable information on the manifestations, morbidity and mortality of SLE patients," said Professor Xiaofeng Zeng, Peking Union Medical College Hospital, China, and lead researcher of the study. "Given that the results suggest many differences in experience of disease between ethnicities, this essential information on this complex disease will provide a vital insight to help patients in the future, and contribute to the international knowledge base on SLE." The CSTAR registry collated data from 106 specialist rheumatology centres and study leaders ensured that all centres utilised the same protocol-directed methods for data collection, including demographic data, clinical history and laboratory and radiological examinations. Patients included in the registry were required to meet four or more of the American College of Rheumatology criteria for the classification of SLE. Evaluations of disease activity were made through completion of the SLE Disease Activity Index (SLEDAI), the British Isles Lupus Assessment Group (BILAG) disease activity index and the physician's global assessment (PGA) of SLE activity. Biological specimens and patient autoantibody profiles were also gathered. CSTAR is supported by the Chinese National Key Technology Research & Development Programme. Abstract Number: FRI0274 NOTES TO EDITORS: For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress Press Office on the 1st floor in Hall 5 of the Congress Centre during EULAR 2010 or on: Email: [email protected] Rory Berrie: Onsite tel: +44 7901 513 297 Caroline Butt: Onsite tel: +44 7789 270 392 About EULAR The European League Against Rheumatism (EULAR) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. In line with The European Union of Medical Specialists (UEMS), EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems. The aims of EULAR are to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with rheumatic diseases. EULAR 2010 is set to be the biggest rheumatology event in Europe with over 15,000 scientists, physicians, allied health professionals, and related audiences in attendance from over 100 countries. Over the course of the congress, almost 300 oral and more than 1600 poster abstract presentations will be featured, with 300 invited speaker lectures taking place in more than 140 sessions. To find out more about the activities of EULAR, visit: www.eular.org

Jun 18, 2010

Blog Entry

Women who consume large amounts of tea have increased risk of rheumatoid arthritis

Rome, Italy, Friday 18 June 2010: Women who drink tea have an increased risk of developing Rheumatoid Arthritis (RA) compared with those who drink none (p=0.04), according to results presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Further results from the same study showed no correlation between the amount of coffee consumption and RA incidence (p=0.16). The results of the US based longitudinal cohort study involving 76,643 women showed a positive association of incident RA in tea drinkers with an increasing Hazard Ratio (HR) observed alongside tea consumption (p=0.03). Consuming any amount of tea carried a significant risk of developing RA (HR 1.40 (95%CI 1.01-1.93) p=0.04) and women who drank ≥4 cups of tea per day had an increased risk of developing RA compared to those who drank none (HR 1.78 (95%CI 0.83-3.82)). An analysis of the method of preparation of coffee (filtered vs unfiltered) and presence or lack of caffeine in the beverage did not show any significant associations with RA or Systemic Lupus Erythematosus (SLE, an autoimmune disease in which the immune system harms the body's own healthy cells and tissues) (RA: filtered p=0.08, unfiltered p=0.38, SLE: filtered p=0.74, unfiltered p=0.97). No increase was shown in the risk of developing RA in participants who drank coffee compared to those that did not (RA: HR 1.09 (95%CI 0.77-1.54 p=0.63). "We set out to determine whether tea or coffee consumption, or the method of preparation of the drinks was associated with an increased risk of RA or SLE -- it is surprising that we saw such differences in results between tea and coffee drinkers," said Professor Christopher Collins, Assistant Professor of Medicine, Georgetown University Medical Center, Washington, USA. "This does make us wonder what it is in tea, or in the method of preparation of tea that causes the significant increase in risk of developing RA." Data on women aged 50-79 were taken from the Women's Health Initiative Observational Study database (a major 15-year research program to address the most common causes of death, disability and poor quality of life in postmenopausal women) where participants completed a self-administered questionnaire providing information on daily consumption of coffee and tea. The relationships between drinking tea and coffee and the risk of RA or SLE were assessed in age-adjusted models and in multivariate Cox proportional hazard models (a statustical approach to estimating survival data). At three years follow up, the diagnosis of incident RA was determined using self-reporting and respondent's feedback on use of disease modifying anti-rheumatic drugs (DMARDS). The variables studied in the RA population were also investigated in women with SLE, but no significant associations were found. "These are very interesting findings and we hope that additional research will investigate this topic further. We do assert the need for caution in the interpretation of these findings as no strong causation effect has been confirmed, and encourage patients with rheumatic diseases to consult their physician before making any significant changes to their diet or caffeine intake" said Professor Paul Emery, President of EULAR and arc Professor of Rheumatology, Leeds Institute of Molecular Medicine, University of Leeds, UK Abstract Number: FRI0108 For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress Press Office on the 1st floor in Hall 5 of the Congress Centre during EULAR 2010 or on: Email: [email protected] Rory Berrie: Onsite tel: +44 7901 513 297 Caroline Butt: Onsite tel: +44 7789 270 392 About EULAR The European League Against Rheumatism (EULAR) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. In line with The European Union of Medical Specialists (UEMS), EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems. The aims of EULAR are to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with rheumatic diseases. EULAR 2010 is set to be the biggest rheumatology event in Europe with over 15,000 scientists, physicians, allied health professionals, and related audiences in attendance from over 100 countries. Over the course of the congress, almost 300 oral and more than 1600 poster abstract presentations will be featured, with 300 invited speaker lectures taking place in more than 140 sessions. To find out more about the activities of EULAR, visit: www.eular.org

Jun 18, 2010

Health

Genealogy may affect clinical differences in systemic lupus erythmatosus patients

Rome, Italy, Friday 18 June 2010: The effects of Systemic Lupus Erythematosus (SLE) may differ based on the individual patient's genealogical heritage, according to results of a new study presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. In particular, the study reinforced differences in SLE phenotype found between Northern and Southern European subpopulations. Results from a Europe-wide study, involving 1,555 SLE patients from nine European countries, showed that photosensitivity was 9.4% more prevalent among patients from the Northern group (p=0.00056) versus the Southern group, while arthritis was 10.7% more prevalent in patients from the Southern group (p=0.0000017) versus the Northern group. These findings replicated results from previous studies. "SLE affects 40 people in every 100,000 in Europe , so our study helps us further understand the impact of this complex disease on patients," said Professor Antonio Gonzalez, Rheumatology Unit, Hospital Clinico Universitario, Santiago de Compostela, Spain, and lead author of the study. Our research reinforces results from previous studies that prove there is evidence of genetic differences between SLE patients from Northern or Southern Europe. Therefore, results from studies in European SLE patients should acknowledge genealogy when reporting clinical differences between patients prior to providing their conclusions." The study compared 475 SLE patients from Northern Europe (Germany, Hungary, The Czech Republic, The Netherlands, and Slovakia) with 1,080 SLE patients from Southern Europe (Greece, Italy, Portugal, and Spain). Investigators analysed the prevalence of the following clinical features between the recruiting centres in the Northern and in the Southern subgroups: serositis, immunologic disorder, malar rash, photosensitivity, arthritis, haematologic disorder, antinuclear antibodies and mean age of disease onset. Abstract Number: FRI0252 For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress Press Office on the 1st floor in Hall 5 of the Congress Centre during EULAR 2010 or on: Email: [email protected] Rory Berrie: Onsite tel: +44 7901 513 297 Caroline Butt: Onsite tel: +44 7789 270 392 About EULAR The European League Against Rheumatism (EULAR) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. In line with The European Union of Medical Specialists (UEMS), EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems. The aims of EULAR are to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with rheumatic diseases. EULAR 2010 is set to be the biggest rheumatology event in Europe with over 15,000 scientists, physicians, allied health professionals, and related audiences in attendance from over 100 countries. Over the course of the congress, almost 300 oral and more than 1600 poster abstract presentations will be featured, with 300 invited speaker lectures taking place in more than 140 sessions. To find out more about the activities of EULAR, visit: www.eular.org

Jun 18, 2010

Health

Expression of certain transporter proteins may predict resistance to drug therapy

Rome, Italy, Friday 18 June: The expression of a transporter protein called the Breast Cancer Resistance Protein (BCRP) in rheumatoid arthritis (RA) patients may indicate higher disease activity and could be a barrier to the effectiveness of disease-modifying antirheumatic drugs (DMARDs), according to the results of a study presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. In a Turkish study, researchers analysed specimens of synovium (the soft tissue that lines the surfaces within joints) from patients with RA who had undergone knee or hip replacement surgery. The presence of BCRP was reported in 41% of samples from RA patients, compared with 0% of samples in the healthy control group. The level of BCRP staining (a technique where a stain specific to a particular protein is used) was more prominent, indicating that the protein was being expressed at higher levels in cells actively involved in the immune response (macrophages, endothelial cells and fibroblasts). Furthermore, of the 40% of RA patients with cells that showed a presence of BCRP, some had a higher concurrent disease activity score (DAS28, an index that rates scores of 28 tender and swollen joints) despite receiving treatment for their condition, when compared with patients without BCRP. Researchers noted that this difference was not statistically significant (4.32±0.32 vs 3.37±1.16, p>0.05). "The results of our study show that the presence of BRCP was only detected in patients with RA and that arguably it is found more prominently in patients with high disease activity," said Dr. Umut Kalyoncu, Hacettepe University Rheumatology Department, Ankara, Turkey, and lead author of the study. "The BCRP protein is a pump involved in transporting substances across the cellular membrane. What we hypothesise is that, due to the location of the cells showing highest levels of BCRP, the presence of this protein may create a barrier for treatments entering the synovium of RA patients. Testing RA patients for the presence of BCRP may help us determine which patients will respond better to certain treatments." Researchers screened samples using histochemical methods from seventeen patients (female n=14) with RA for the presence of p-glycoprotein (a protein involved in the transport of various molecules across cellular membranes), BCRP and multidrug resistance protein 1 and compared with samples taken from a control group of healthy controls and other inflammatory (ankylosing spondylitis, juvenile chronic arthritis) and non-inflammatory (osteoarthritis) rheumatic diseases. Prior to surgery, 53% of patients were taking methotrexate, 47% were taking sulphasalazine, 70% hydroxychloroquine, 18% leflunomide and 12% were taking anti-TNF drugs. Abstract Number: FRI0129 For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress Press Office on the 1st floor in Hall 5 of the Congress Centre during EULAR 2010 or on: Email: [email protected] Rory Berrie: Onsite tel: +44 7901 513 297 Caroline Butt: Onsite tel: +44 7789 270 392 About EULAR The European League Against Rheumatism (EULAR) is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. In line with The European Union of Medical Specialists (UEMS), EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems. The aims of EULAR are to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with rheumatic diseases. EULAR 2010 is set to be the biggest rheumatology event in Europe with over 15,000 scientists, physicians, allied health professionals, and related audiences in attendance from over 100 countries. Over the course of the congress, almost 300 oral and more than 1600 poster abstract presentations will be featured, with 300 invited speaker lectures taking place in more than 140 sessions. To find out more about the activities of EULAR, visit: www.eular.org

Jun 18, 2010

Health

Anxiety/panic disorder most frequent disabling comorbid disorder in TS patients, study finds

BUFFALO, N.Y. -- An assessment of patients with adult Tourette syndrome (TS) to identify clinical factors that contribute to psychosocial and occupational disabilities resulting from the vocal or motor tics that define TS found that anxiety/panic disorder may be the most disabling psychiatric condition associated with the disorder. The results of the study, based on the Global Assessment of Functioning (GAF) scale, will be used to identify patients who are more likely to have or develop significant disabilities related either to the severity of their tics, or to the psychiatric disorders associated with TS, such as obsessive-compulsive disorder, mood disorders and drug or alcohol abuse. Results were presented today (June 17) at the 14th International Congress on Parkinson's Disease and Movement Disorders, being held in Buenos Aires, Argentina, June 14-17. David G. Lichter, MD, professor of clinical neurology in the University at Buffalo's School of Medicine and Biomedical Sciences, is first author. "Our study identified the most significant predictors of disability, says Lichter. "Now having identified these at-risk patients, we can follow them more closely and begin appropriate interventions as early as possible." Lichter also noted that the finding of anxiety/panic disorder as the most-disabling psychiatric disorder associated with TS was unexpected. "The main surprise was that depression was not a major predictor of psychosocial or occupational disability in these patients," says Lichter. "Depression has been identified as an important predictor of quality of life in TS. Tics, both motor and vocal, are the primary symptoms of Tourette syndrome. Vocal tics are involuntary sounds, such as whistles, hums, or throat clearing. Complex vocal tics can be repeating words or phrases or involuntary swearing. Motor tics are muscle spasms, such as involuntary eye blinks, shoulder shrugs, repetitive kicking, head jerks, eye darts and nose twitches. In most patients, tics wane after mid-to-late adolescence. However, the study data indicates that in those patients whose tics persist into adulthood, tic severity remains the primary factor contributing to global psychosocial and occupational disability, according to Lichter. "In many TS adults, motor tics remain more enduring and prominent than vocal tics and, in our study, motor tics were more severe overall than vocal tics and were more closely correlated with GAF scale score," says Lichter. The study involved 66 patients -- 45 male and 21 female -- who had been followed for an average of 8.2 years at a UB-based TS clinic. They ranged in age from 20 to 80. Results showed that nearly 32 percent were diagnosed with obsessive-compulsive disorder (OCD), while 62 percent showed OCD behavior. Nearly 29 percent had anxiety/panic disorder with another 21 percent exhibiting anxiety symptoms. Prevalence of other TS-associated conditions were depression (16.7 percent), depressed mood (12.1 percent), bipolar disorder (12.1 percent), rage attacks and severe self-injury behavior (4.5 percent), childhood ADHD history (33.3 percent), adult ADD (18.2 percent), substance-use disorder (22.7 percent) and psychosis and restless legs syndrome (1.5 percent). In the future Lichter and colleagues plan to collect prospective data on both quality of life and psychosocial and occupational functioning in TS patients. "We will look more closely at the interactions of tic severity, mood disorders, substance abuse and social support systems and determine how these issues relate to personal and social/occupational adjustment," Lichter says. "We hope this information will help us improve the lives of our TS patients, especially those who are at highest risk for a poor outcome." Sarah G. Finnegan, MD, PhD, UB assistant professor of neurology, is co-author of the study. The University at Buffalo is a premier research-intensive public university, a flagship institution in the State University of New York system and its largest and most comprehensive campus. UB's more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.

Jun 17, 2010

Earth & Environment

New analysis on problems between archaeology and pharaonic chronology, based on radiocarbon dating

BEER-SHEVA, ISRAEL June 17, 2010 -- In a just published article in Science magazine (June 18, 2020), Prof. Hendrik J. Bruins of Ben-Gurion University of the Negev presents novel implications related to new developments in the radiocarbon dating of Pharaonic Egypt. The article reports that, for the first time, it is possible to relate the Minoan Santorini eruption with Egyptian Historical Chronology solely on the basis of radiocarbon dates. Thus, it appears that the eruption preceded the 18th Dynasty and occurred during the Hyksos Period. Moreover, conventional association of Egyptian history with archaeological phases at Tell el-Dab'a, the ancient capital of the Hyksos, located in the northeastern region of the Nile delta, do not fit in terms of radiocarbon dating. Bruins is a researcher in the University's Department of Man in the Desert at the Jacob Blaustein Institutes for Desert Research and is affiliated with the Department of Bible, Archaeology and Ancient Near Eastern Studies. His research focuses on the 2nd millennium B.C. "Major problems exist here in relation to the Santorini eruption between archaeological dating, radiocarbon dating and association between archaeological strata in the field and Egyptian Historical Chronology," said Bruins. In 2006, Bruins received the Dutch Royal Award -- Officer in the Order of Orange-Nassau -- in the name of Her Majesty Queen Beatrix for achievements in policy-oriented studies on drought, hazard assessment and contingency planning in drylands, geo-archaeological desert research and innovative chronological studies about the ancient Near East. He first came to Ben-Gurion University in 1976 as an instructor in the Department of Geography, then worked in the early 1980s for the Israel Antiquities Authority in the framework of the Negev Emergency Archaeological Survey. Bruins developed novel geo-archaeological research techniques, pioneered excavations in ancient agricultural terraces in the Negev highlands and discovered extensive tsunami deposits in Crete (Palaikastro), related to the Minoan Santorini eruption. He also carried out research at the Ein el-Qudeirat oasis of northeastern Sinai, associated by some scholars with biblical Kadesh-Barnea. There, he became aware of the vital need to measure time in both archaeological and environmental studies with the same methodology: radiocarbon dating. This was the beginning of innovative research in cooperation with one of the best radiocarbon labs in the world situated at the University of Groningen in the Netherlands. Several major archaeological sites in Israel are currently under investigation, as well as rural desert sites in the Negev. For more information, contact Prof. Hendrik Bruins, [email protected]; office: 972-8-6596863; cell: 972-52-3930392 About American Associates, Ben-Gurion University of the Negev American Associates, Ben-Gurion University of the Negev (AABGU) plays a vital role in sustaining David Ben-Gurion's vision, creating a world-class institution of education and research in the Israeli desert, nurturing the Negev community and sharing the University's expertise locally and around the globe. With some 20,000 students on campuses in Beer-Sheva, Sede Boqer and Eilat in Israel's southern desert, BGU is a university with a conscience, where the highest academic standards are integrated with community involvement, committed to sustainable development of the Negev. For more information, please visit www.aabgu.org.

Jun 17, 2010